U.S. Air Force service behind our leadership — C-17 Globemaster III operations.
SDVOSB · Registered in SAM.gov
Advancing Health Through Science, Service & Innovation
Valorix BioSolutions is a Service-Disabled Veteran-Owned Small Business delivering research-driven biotech and wellness solutions that support U.S. national priorities.
Primary NAICS codes spanning biotech R&D, testing, and diagnostics.
Focus on compliance, quality, and measurable performance.
About Valorix
Military precision, applied to bioscience.
Our Story
Valorix BioSolutions was founded in 2026 by Daniel Torgerson, a Service-Disabled Veteran with a deep commitment to service and scientific advancement.
Drawing from military experience and a keen interest in biotechnology, Daniel established Valorix to bridge the gap between cutting-edge research and real-world applications. The company was formed in Puerto Rico to leverage the island’s growing life sciences ecosystem while maintaining strong connections to federal research and contracting opportunities.
From the beginning, Valorix has focused on three interconnected areas: supporting government biomedical research needs, developing innovative technologies through non-dilutive funding programs, and creating science-backed wellness solutions.
Our Mission
To deliver innovative biotechnology solutions that strengthen health security and advance scientific research in support of national priorities.
Our Core Values
- Mission focus
- Scientific integrity
- Operational resilience
- Veteran leadership
- Translational impact
- Responsible commercialization
Capabilities
Delivering technical expertise and mission-focused solutions
A focused set of capabilities designed to support both federal and commercial partners.
01
Research & Development
Biotechnology R&D, experimental design, and technical problem-solving in support of health security and scientific priorities.
02
Technical Consulting
Scientific and technical consulting services related to biotechnology, diagnostics, and applied research.
03
Program & Project Leadership
Experienced leadership managing complex operations, personnel, and mission requirements — drawn from extensive military operational experience.
04
Federal Contracting Readiness
Structured to support SDVOSB set-aside and sole-source opportunities, with strong emphasis on compliance and performance.
05
Collaborative Research
Partnering with research institutions, technical experts, and government stakeholders on SBIR/STTR and related programs.
06
Research-use Assay Development
Development of research-use functional assays, biomarker platforms, and preclinical testing workflows for biotechnology, diagnostics, and therapeutic discovery.
Have a requirement in mind?
Tell us the mission and we will tell you, plainly, whether Valorix is the right fit.
Start a conversationFederal Contracting
Supporting government missions with reliable biomedical expertise
Valorix BioSolutions is structured to support federal agencies through sole-source and set-aside contracting opportunities as a Service-Disabled Veteran-Owned Small Business.
Why partner with Valorix
- Service-Disabled Veteran-Owned Small Business (SDVOSB)
- Strong operational leadership and program management experience
- Focus on mission-critical health and biotechnology solutions
- Agile small-business structure capable of rapid response
- Commitment to compliance, quality, and performance
We are registered in SAM.gov and are actively pursuing opportunities aligned with our technical capabilities in biotechnology research and development, diagnostics, health security, and related scientific services.
Valorix is positioned to partner with universities, medical centers, federal agencies, and prime contractors to advance early-stage biotechnology programs through SBIR/STTR, federal R&D contracts, and translational research collaborations.
Primary NAICS codes
- 541714Research & Development in Biotechnology
- 541715R&D in Physical, Engineering & Life Sciences
- 541380Testing Laboratories
- 541690Other Scientific & Technical Consulting
- 325413In-Vitro Diagnostic Substance Manufacturing
We welcome opportunities to support federal requirements through SBIR/STTR programs, sole-source awards, and competitive set-asides.
Innovation & Research
Research with real-world application
We pursue R&D aligned with national priorities — rapid detection, biosecurity, and innovative approaches to health challenges — guided by a practical, mission-oriented approach that emphasizes usable outcomes and operational relevance.
Biotechnology R&D
Applied research programs built to produce usable results, not just papers — with experimental design and technical problem-solving at the core.
Diagnostic & Detection Technologies
Approaches that support rapid, reliable detection — an area where speed and accuracy translate directly into mission outcomes.
Health Security & Biodefense
Technologies and solutions supporting detection, response, and protection related to public-health threats — enhancing preparedness and response capability.
Molecular Imaging Platforms
Technologies enabling detailed visualization of biological processes at the molecular level — improved research capability with potential diagnostic applications.
These platforms represent our current focus areas. We continuously evaluate new opportunities where our expertise can create meaningful value, and we actively seek SBIR/STTR opportunities and collaborative research partnerships.
Programs in Development
Active research programs advancing toward collaboration and federal opportunity
01
Alpha-Gal Syndrome Functional Biomarker Program
Valorix is developing research-use functional biomarker approaches for alpha-gal syndrome and related tick-associated health conditions. This program focuses on stool-based and microbiome-linked functional readouts that may help researchers better understand disease-associated changes in gut biology, immune activation, and metabolic function. The program is currently in development and is intended for collaborative R&D, federal grant applications, and research partnerships. It is not currently offered as a diagnostic test.
02
Bioluminescent Antibody Uptake and Internalization Platform
Valorix is developing a bioluminescent reporter platform to support therapeutic antibody and antibody-drug conjugate research. The technology is designed to measure antibody binding, cellular internalization, intracellular processing, and functional payload delivery using a sensitive light-based readout. This approach may provide real-time kinetic data, improve antibody candidate selection, and reduce the cost and risk of early therapeutic development. The platform is intended for research use, preclinical assay development, and collaborative programs with academic, industry, and federal partners.
In development
Wellness products, grounded in scientific principles
Alongside our research and federal contracting work, Valorix is developing commercial wellness and supplement solutions. Our approach emphasizes quality, transparency, and practical benefit — bringing thoughtfully developed products to market that align with our broader commitment to health and performance.
Quality
Formulation and sourcing standards held to the same rigor we apply to research work.
Transparency
Clear labelling and honest claims — no overstatement of what a product does.
Practical benefit
Products designed around real outcomes for health and performance.
This product line is currently under development as part of our long-term commercialization strategy.
Our Team
Leadership
Daniel Torgerson
Founder & Chief Executive Officer
26 years of U.S. Air Force service as a C-17 Globemaster III crewmember and Senior Non-Commissioned Officer, including leading teams of up to 120 personnel and training the Qatar Emiri Air Force on C-17 operations.
Contact
Let's discuss your mission
We welcome inquiries from federal agencies, prime contractors, research partners, and commercial organizations. For federal contracting opportunities or technical collaboration, please reach out directly.
-
Headquarters
Valorix BioSolutions LLC
104 Urb. Vista Del Mar
Mayagüez, Puerto Rico 00682 - Email danieltorgerson@valorixbio.com
- Phone (636) 219-1488